Skip to content

KDVgyn

Active
Private limited companyfounded 2023active for 3 yearsPaalsteenstraat 66, 3500 Hasselt, BelgiumKBO/BCE: BE 0804.435.747

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

KDVgyn has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €121,028 and a net result of €92,939. The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

KBO
Status
Active since 01-08-2023 Normal situation
Legal form
Private limited company
Registered office
Paalsteenstraat 66, 3500 Hasselt
Activity
“De vennootschap heeft tot doel de uitoefening van de geneeskunde,specialisatie gynaecologie door de geneesheer…” (deed in Dutch)From the articles, 11 activitiesNo NACE code in the KBO yet
Establishment unit
2.348.268.347 3500 Hasselt, since 01-08-2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€132,327
▲ 163%
Turnover
≈ €330,000
estimated
Profit
€92,939
▲ 303%
Equity
€121,028
▲ 331%
Total assets
€179,489
▲ 119%
2025 accounts filed 191 days before the deadline
Filed on 21-01-2026PDF
Score breakdownraises riskFounded in 2023lowers riskLiquidity: current ratio 3.93, cash €119,662Size: total assets €179,489Equity €121,028 (67.4% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 82% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 92+33
equity 67.4% of total assets
Liquidity 93+4
short-term debt 21.1% · cash 66.7%
Profitability 100=
return on assets 51.8%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 2.9% 12-2024: 3.1%▲ +0.2 percentage points vs 11-2024 01-2025: 3.4%▲ +0.3 percentage points vs 12-2024highest value 02-2025: 3.4%● unchanged vs 01-2025highest value 03-2025: 0.9%▼ -2.5 percentage points vs 02-2025 04-2025: 0.9%● unchanged vs 03-2025 05-2025: 0.9%● unchanged vs 04-2025 06-2025: 0.9%● unchanged vs 05-2025 07-2025: 0.9%● unchanged vs 06-2025 08-2025: 1.2%▲ +0.3 percentage points vs 07-2025 09-2025: 1.2%● unchanged vs 08-2025 10-2025: 1.2%● unchanged vs 09-2025 11-2025: 1.2%● unchanged vs 10-2025 12-2025: 1.2%● unchanged vs 11-2025 01-2026: 1.2%● unchanged vs 12-2025 02-2026: 0.2%▼ -1.0 percentage point vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026lowest value 05-2026: 0.2%● unchanged vs 04-2026lowest value 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026lowest value 08-2026: 0.2%● unchanged vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.93 (1.81 in 2024), above the usual 1.5. Short-term debt is 21.1% and cash 66.7% of total assets. 32.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 56% of them on solvency, 84% on liquidity, 90% on profitability and 97% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 3.93, cash €119,662
NBB · annual accounts
lowers risk · Size: total assets €179,489
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €121,028 (67.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-01-2026, 191 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
191 days early
2024
162 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 177 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Financials · financial year 2025, micro format

Latest annual accounts filed

Annual accounts 2025

Download PDF
Financial year ended
31-12-2025
Filed on
21-01-2026
Format
micro format
Reference
2026-00010944
Turnover
≈ €330,000
Estimated: probably between €220,000 and €510,000
Total assets
€179,489▲ 119%
2024 · €82,082
Net result
€92,939▲ 303%
2024 · €23,089
Working capital
€110,736▲ 527%
2024 · €17,670
Trend over the years

2024 to 2025, 2 financial years

The operating result for 2025 is over 3.5 times that of 2024.

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Operating result€120,333 2025 Net result€92,939 2025

Use the arrow keys on the chart for the figures per year.

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€34,029-€120,333▲ 254%
Net result€23,089-€92,939▲ 303%
Equity€28,089-€121,028▲ 331%
Total assets€82,082-€179,489▲ 119%
Debt€53,993-€58,461▲ 8.3%
Working capital€17,670-€110,736▲ 527%
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €179,489
Fixed assets €30,924 ▼ 27.6%
Current assets €148,566 ▲ 278%
Equity and liabilities €179,489
Equity €121,028 ▲ 331%
Debt €58,461 ▲ 8.3%
Debt's share of the balance-sheet total falls from 65.8% to 32.6%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€132,137▲
2024 · €49,778
Cash flow
€104,744▲
2024 · €38,838
Current ratio
3.93▲
2024 · 1.81
Debt to equity
0.48▼
2024 · 1.92
ROE
76.8%▼
2024 · 82.2%
ROA
51.8%▲
2024 · 28.1%
Interest coverage
73.53▲
2024 · 15.13
Debt ≤ 1 year
€37,829▲
2024 · €21,683
Debt > 1 year
€20,632▼
2024 · €32,310
Income taxes
€25,896▲
2024 · €7,649
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Companies with the same profile, two years later

Historical observation

In July 2024, 39,278 companies had the same profile as KDVgyn has now. Two years later, 1.8% had gone bankrupt and 95.9% were still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.9% was still going

The bankruptcy probability of KDVgyn itself is lower: 0.2% within 12 months. It rests on far more data about KDVgyn than the profile alone.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for KDVgyn. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines

Source: Annual accounts 2025 (PDF), filed on 21-01-2026.

Balance sheet Code20242025
Assets
Total assets20/58€82,082€179,489▲
Fixed assets21/28€42,728€30,924▼
Tangible fixed assets22/27€42,728€30,924▼
Furniture and vehicles24€42,728€30,924▼
Current assets29/58€39,353€148,566▲
Amounts receivable after more than one year29-€10,000
Other amounts receivable291-€10,000
Current investments50/53€7,000€18,904▲
Cash at bank and in hand54/58€32,353€119,662▲
Equity and liabilities
Total equity and liabilities10/49€82,082€179,489▲
Equity10/15€28,089€121,028▲
Contributions10/11€5,000€5,000=
Contributions outside capital11€5,000-
Other1109/19€5,000-
Reserves13€23,089€116,028▲
Distributable reserves133€23,089€116,028▲
Amounts payable17/49€53,993€58,461▲
Amounts payable after more than one year17€32,310€20,632▼
Financial debts170/4€32,310€20,632▼
Amounts payable within one year42/48€21,683€37,829▲
Current portion of amounts payable after more than one year42€11,180€11,678▲
Trade debts44-€113
Suppliers440/4-€113
Taxes, remuneration and social security45€7,649€25,896▲
Taxes450/3€7,649€25,896▲
Other amounts payable47/48€2,854€141▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15,749€11,805▼
Other operating charges640/8€582€190▼
Gross operating margin9900€50,359€132,327▲
Operating profit (loss)9901€34,029€120,333▲
Financial income75/76B-€300
Recurring financial income75-€300
Financial charges65/66B€3,291€1,797▼
Recurring financial charges65€3,291€1,797▼
Profit (loss) for the period before taxes9903€30,738€118,836▲
Income taxes67/77€7,649€25,896▲
Profit (loss) for the period9904€23,089€92,939▲
Profit (loss) for the period to be appropriated9905€23,089€92,939▲
Appropriation of the result
Profit (loss) to be appropriated9906€23,089€92,939▲
Transfer to equity691/2€23,089€92,939▲
To other reserves6921€23,089€92,939▲

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15,749€11,805▼ 25.0%
Other operating charges640/8€582€190▼ 67.4%
Gross operating margin9900€50,359€132,327▲ 163%
Operating profit (loss)9901€34,029€120,333▲ 254%
Financial income75/76B-€300-
Recurring financial income75-€300-
Financial charges65/66B€3,291€1,797▼ 45.4%
Recurring financial charges65€3,291€1,797▼ 45.4%
Profit (loss) for the period before taxes9903€30,738€118,836▲ 287%
Income taxes67/77€7,649€25,896▲ 239%
Profit (loss) for the period9904€23,089€92,939▲ 303%
Profit (loss) for the period to be appropriated9905€23,089€92,939▲ 303%
Line20242025Change
Assets
Total assets20/58€82,082€179,489▲ 119%
Fixed assets21/28€42,728€30,924▼ 27.6%
Tangible fixed assets22/27€42,728€30,924▼ 27.6%
Furniture and vehicles24€42,728€30,924▼ 27.6%
Current assets29/58€39,353€148,566▲ 278%
Amounts receivable after more than one year29-€10,000-
Other amounts receivable291-€10,000-
Current investments50/53€7,000€18,904▲ 170%
Cash at bank and in hand54/58€32,353€119,662▲ 270%
Equity and liabilities
Total equity and liabilities10/49€82,082€179,489▲ 119%
Equity10/15€28,089€121,028▲ 331%
Contributions10/11€5,000€5,000=
Contributions outside capital11€5,000--
Other1109/19€5,000--
Reserves13€23,089€116,028▲ 403%
Distributable reserves133€23,089€116,028▲ 403%
Amounts payable17/49€53,993€58,461▲ 8.3%
Amounts payable after more than one year17€32,310€20,632▼ 36.1%
Financial debts170/4€32,310€20,632▼ 36.1%
Amounts payable within one year42/48€21,683€37,829▲ 74.5%
Current portion of amounts payable after more than one year42€11,180€11,678▲ 4.5%
Trade debts44-€113-
Suppliers440/4-€113-
Taxes, remuneration and social security45€7,649€25,896▲ 239%
Taxes450/3€7,649€25,896▲ 239%
Other amounts payable47/48€2,854€141▼ 95.0%
Line20242025Change
Profit (loss) for the period9904€23,089€92,939▲ 303%
+ Depreciation and write-downs630€15,749€11,805▼ 25.0%
Operating cash flow (approximation)€38,838€104,744▲ 170%
Investment in fixed assets (approximation)-€0-
Change in cash-€87,308-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference Document
31-12-2025 micro format 21-01-2026 2026-00010944 PDF
31-12-2024 micro format 19-02-2025 2025-00036282 PDF

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2023
DE VOCHT Karlijn
Director · appointed in the act of 03-08-2023 · listed in the 2025 annual accounts, filed on 21-01-2026
Current

Mandate history

1 person, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
DE VOCHT Karlijn
  • Director, appointed in the act of 03-08-2023, still in office
See the board, name and registered office on a given date →

The board according to the articles of association

Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
Board ruleThese rules set how the board is made up, meets and takes decisions.
“1, al dan niet aandeelhouder”
“Iedere bestuurder alleen optredend mag alle handelingen stellen nodig of nuttig voor verwezenlijking voorwerp, indien meer dan een…”

Articles of association, deed of 03-08-2023

Owners and capital

Capital transactions

Shareholders according to the deeds
At incorporation act of 03-08-2023 ↗
Capital over time
  1. 03-08-2023 Incorporation · €5,000 · 100 shares

Other provisions of the articles of association

Other provisionsThese rules from the articles cover subjects other than the board, the shares, the purpose and the meetings.
“Te bestemmen winst zoals bepaald door geldend boekhoudrecht wordt verdeeld door algemene vergadering met inachtneming van geldend…”
1 more provision in the deed, see the deed of 03-08-2023

Articles of association, deed of 03-08-2023 (in Dutch)

Group and network

Connections & network

1 current director
Depth

The network starts from the directors of KDVgyn. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 1 August 2023, KDVgyn was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 DE VOCHT Karlijn is director of the company, appointed in the act of 03-08-2023.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 03-08-2023
  3. 3National Bank, annual accounts 2025

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
21-01
NBB filing Annual accounts filedPDF
financial year 2025 · micro format
2025
31-12
Financial Liquidity more than doubledcurrent ratio 3.93
The current ratio rises from 1.81 to 3.93.
31-12
Financial Equity above €100,000equity €121,028 ▲331%
With a profit in every financial year since 2024, equity grows to €121,028.
19-02
NBB filing Annual accounts filedPDF
financial year 2024 · micro format
2023
03-08
Gazette deed Incorporation
Appointment: DE VOCHT Karlijn (director) · Founder · Founding capital7 points ▸
  • Founder, DE VOCHT Karlijn
  • Incorporation, 31-07-2023
  • Founding capital, €5,000
  • Bank account, “Bank Van Breda, vennootschap in oprichting” (deed in Dutch)
  • DE VOCHT Karlijn holds 100 shares
  • Other provision, “beschikking over stortingen”, 5000 (deed in Dutch)
  • Director appointment, DE VOCHT Karlijn (director)

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

Register details

Identity

KBO record
Name KDVgyn in Dutch
Enterprise number 0804.435.747
Legal form Private limited company
Status Active, normale toestand
Founded 01-08-2023
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 03-08-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Paalsteenstraat 66,3500 Hasselt, bestuursorgaan mag exploitatiezetels oprichten of opheffen wanneer en waar nodig zonder wijziging…”
deed of 03-08-2023 (in Dutch)

Registered office and establishments

Registered office Paalsteenstraat 66, 3500 Hasselt, Belgium
Establishments 1 establishment unit since 2023

Activities

PurposeThe purpose describes the activities the company may carry out under its articles.
“De vennootschap heeft tot doel de uitoefening van de geneeskunde,specialisatie gynaecologie door de geneesheer vennoot,met inachtneming van…”
11 activities
  1. De vennootschap heeft tot doel de uitoefening van de geneeskunde,specialisatie gynaecologie door de geneesheer vennoot,met inachtneming van de regels van de Medische Plichtenleer.
  2. Het inrichten van de praktijk voor de geneeskunde,de uitvoering van de technische,medische,radiografische en laboratoriumprestaties in verband met voormelde discipline.
  3. De aankoop en het huren van alle medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten.
  4. Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nuttig of nodig zijn voor de uitoefening van bovenvermelde activiteiten.
  5. De mogelijkheid scheppen om een geneesheer-vennoot toe te laten zich verder te bekwamen teneinde in zijn discipline aan de spits van de evolutie te blijven.
  6. Zij mag alle financiele activiteiten en alle onroerende en roerende verrichtingen stellen welke rechtstreeks verband houden met de verwezenlijking van haar maatschappelijk doel of welke van aard zijn de verwezenlijking ervan te vergemakkelijken.
  7. De vennootschap mag als bijkomstig doel alle roerende- of onroerende verhandelingen doen,mits dit een beheren is als goede huisvader en niet als aanvullende commerciele activiteit.
  8. Bovendien kan de vennootschap informatie verstrekken en of onderricht geven in de breedste betekenis van het woord,zonder vorm van aanvullende commerciele activiteit.
  9. De vennootschap mag samenwerken met alle ondernemingen die een gelijkaardig doel nastreven.
  10. De vennootschap kan deelnemen in kostenassociaties of middelenvennootschappen van geneesheren.
  11. De vennootschap kan tevens lid zijn van een vereniging zonder winstgevend doel van geneesheren.

The full purpose is in the deed

deed of 03-08-2023 (in Dutch)

Invoicing and payment

VAT number BE 0804.435.747
E-invoicing via Peppol
Not found in the Peppol Directory

This enterprise or VAT number is not in the Peppol Directory. Being listed there is voluntary, so the company can still receive invoices via Peppol.

Next steps

Try sending from your invoicing software. If that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance

Follow this company and you will hear the next morning if it appears in the Peppol register.

Register as of 1 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Friday of June
deed of 03-08-2023 (in Dutch)

The scores and ratios are Checked's own calculations, not a credit decision.

Environmental permits: No permit applications found in Flanders.

Sites & property

Location
registered office establishment The establishment unit on the map
2 companies at this address See who is registered here
1 establishment unit
KDVgyn
Stadsomvaart 11, 3500 HasseltSpecialist medical practice
since 2023unit number 2.348.268.347

Buildings and parcels at the addresses

Ground area
4.2 ha
Building footprint
1.2 ha
Building volume
873 m³
2 parcels, Flanders · tallest building 8.6 m.
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
71328D0168/00L000 Flanders 4.1 ha 1 · 1.2 ha -
71327G0116/00R004 Flanders 965 m² 1 · 155 m² 8.6 m · 2